Coronary Heart Disease And Blood Glucose Abnormalities Of Traditional Syndrome Differentiation And ZeXieDanMingYin Intervention Research

Objective:Explore cardiovascular hospitalized patients with abnormal condition of sugar metabolism, Coronary Heart Disease merger 2-hour postprandial glucose patient of Traditional Syndrome rule, observe CEC in Coronary Heart Diseas, it with diabetes mellitus and coronary merger 2-hour postprandial glucose abnormalities in patients with level changes and discrepancy and oral ZeXieDanMingYin and rational lifestyle intervention six weeks after observe its blood glucose, lipid profile and circulatory endothelial cell parameters such changes.Methods:Select January 2010 to September 2010 period, in Xinjiang Medical University affiliated hospital of traditional hospitalized patients diagnosed Coronary Heart Disease,Coronary Heart Disease with diabetes and Coronary Heart Disease merge 2-hour postprandial glucose patients, observe CEC quantity change, Coronary Heart Disease merge 2-hour postprandial glucose patients, according to Traditional Syndrome 6 dialectical divided into XunXueYuZu, QiZhiXinXiong, TanZhuoBiZu, QiYinLiangXu, XinShenYinXu, XinShenYangXu, analyzing its characteristics. The control group were randomly divided into two groups, with western medicine foundation treatment, including regular enlarge crowns, lipid, step-down treatment such as, but not taking oral, The treatment group based in western medicine treatment combined with alisma orientalis Dan Ming drinks and rational lifestyle intervention six weeks observation blood sugar, blood fat and circulatory endothelial cell parameters such changes.Results:1,2-hour postprandial glucose rate in Coronary inpatients 62% 2,Traditional syndrome differentiations with TanZhuoBiZu type at most, followed by most XinXueYuZu type,3,When 2-hour postprandial glucose the circulatory endothelial cell significantly higher than CHD group.4,Add ZeXieDanMingYin and rational lifestyle intervention six weeks after can significantly reduce TC,TG,LDL-C, PBG (P< 0.05), HDL-C,LDL-C without opparent change (P> 0.05), a clinical medicine effect is better (P< 0.05).Conclusion:China coronary inpatients in the vast majority of merger sugar metabolic abnormalities, and need through OGTT experiments to accurately find these merger with abnormal glucose metabolism, always detection FPG diagnosis most sugar metabolic abnormalities. Through the Traditional Syndrome differentiation coronary heart disease merger 2-hour postprandial glucose in the process, we found that the most common TanZhuoBiZu, so we think in clinical medicine treatment on the basis of add with HuaTanTongLuo drug of traditional Chinese medicine to preventing coronary heart disease merger 2-hour postprandial glucose, reduce the morbidity and mortality in patients with, raise its quality of life has the extremely vital significance.